WHO needs more data to approve Sputnik V for emergency use

Washinton, 11/9: The World Health Organization has sought some more data from Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, developer of Covid-19 vaccine Sputnik V for according Emergency Use Listing status for the jab.

Sputnik V is currently manufactured in India and being sold by Dr Reddy’s Laboratories under Emergency Use Authorisation route. According to WHO website, though several meetings were held as part of the process for EUL, the status of assessment column says “On hold, awaiting completion of rolling submission”.